Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma): Statistics

Aprobado por la Junta Editorial de Cancer.Net, 02/2021

ON THIS PAGE: You will find information about the number of people who are diagnosed with Waldenstrom macroglobulinemia each year. You will also read general information on surviving the disease. Remember, survival rates depend on several factors. Use the menu to see other pages.

Waldenstrom macroglobulinemia is uncommon. Each year, an estimated 1,000 to 1,500 adults in the United States are diagnosed with the disease. 

The chance of developing Waldenstrom macroglobulinemia increases as people age. The average age of diagnosis is 70. The disease is less common in women than men and is far less common in Black people than white people.

The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rate for people with Waldenstrom macroglobulinemia is about 78%. However, it is important to note that survival rates vary based on a number of individual factors, including the patient’s age, how advanced the disease is at the time of diagnosis, and whether the patient has other medical problems.

It is important to remember that statistics on the survival rates for people with Waldenstrom macroglobulinemia are an estimate. The estimate comes from annual data based on the number of people with this cancer in the United States. Also, experts measure the survival statistics every 5 years. So the estimate may not show the results of better diagnosis or treatment available for less than 5 years. Talk with your doctor if you have any questions about this information. Learn more about understanding statistics.

Statistics adapted from the American Cancer Society website (source accessed February 2021).

The next section in this guide is Risk FactorsIt explains the factors that may increase the chance of developing Waldenstrom macroglobulinemia. Use the menu to choose a different section to read in this guide.